Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical practice, says GlobalData

NewAmsterdam Pharma has completed the enrollment of 407 patients in the pivotal Phase III TANDEM clinical trial evaluating obicetrapib in combination with ezetimibe in patients with heterozygous familial hypercholesterolemia (HeFH) and/or atherosclerotic cardiovascular disease (ASCVD). Obicetrapib has demonstrated strong tolerability in more than 800 patients with elevated lipid levels in NewAmsterdam’s clinical trials to date. […]
Read more

Electrophysiology ablation catheter market poised to reach $15 billion in 2033, forecasts GlobalData

Pulsed-field ablation (PFA) catheters are now available in several countries across North America, Europe, Asia-Pacific, and Middle East and Africa. Interestingly, the average selling price of PFA catheters is approximately $2,000 to $3,000, more than the average ablation catheter. PFA catheters have become increasingly popular amongst physicians, so much so that that the electrophysiology (EP) […]
Read more

Healthcare’s growing reliance on tech demands robust cybersecurity measures, says GlobalData

The healthcare industry is increasingly dependent on digital technologies and interconnected medical devices, which has heightened the importance of cybersecurity. Given the growing dependence on technology in healthcare, there is a pressing need for increased spending on medical device security, a thorough understanding of the implications of expanding interconnectivity, and the need for robust cybersecurity […]
Read more

Mabwell leads development of new generation nectin-4 ADCs in China for triple-negative breast cancer, says GlobalData

Mabwell (Shanghai) Bioscience recently received the National Medical Products Administration (NMPA) approval for its 9MW2821, a novel nectin-4 targeting ADC (antibody-drug conjugate), to enter Phase II clinical trial in China. The preliminary clinical results of the Phase I/II study presented at the 2024 American Society of Clinical Oncology (ASCO) annual meeting demonstrated promising efficacy in […]
Read more

Nipro looks to meet advanced medical devices demand in US with $398 million facility in North Carolina, says GlobalData

Nipro Medical Corporation, a wholly-owned subsidiary of Japan-based Nipro Corporation,  plans to invest $398 million in constructing a medical device facility in North Carolina. This strategic investment underscores Nipro’s commitment to support the growing demand for advanced medical devices such as dialysis products, infusion pumps, and critical care equipment in the US market, says GlobalData, […]
Read more

Early cancer detection in Singapore advances with innovative partnerships, finds GlobalData

Cancer is a global health challenge where early detection is critical for better patient outcomes. Traditional cancer detection techniques, such as imaging and biopsy, often diagnose the disease at advanced stages, reducing the chances of successful treatment. Against this backdrop, new partnerships in Singapore are facilitating access to innovative early-stage cancer detection methods, leveraging advanced […]
Read more

Paul, Weiss, Rifkind, Wharton & Garrison and Kirkland & Ellis top M&A legal advisers in construction sector in H1 2024, reveals GlobalData

Paul, Weiss, Rifkind, Wharton & Garrison and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers in the construction sector during the first half (H1) of 2024 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, which ranks legal advisers by the value and volume of […]
Read more

Telecom and pay-TV services revenue in Australia to increase at 2.1% CAGR over 2023-2028, forecasts GlobalData

The total telecom and pay-TV services revenue in Australia is expected to increase at a compound annual growth rate (CAGR) of 2.1% over the forecast period 2023-2028, led by the growth in mobile data and fixed broadband service segments, according to GlobalData, a leading data and analytics company. GlobalData’s Australia Telecom Operators Country Intelligence Report […]
Read more
1 … 122 123 124 125 126 … 776